Tuuli Lappalainen, PhD, assistant professor at New York Genome Center and Columbia University, seeks to understand the connections between genetic variants and gene expression patterns. Studying genome-wide association data, Lappalainen and her team of researchers are paving the way toward identifying how genetic differences may affect gene expression—and an individual’s risk for certain diseases.
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015.
Subscribe to the Illumina video channel